CASIRIVIMAB
COVID-19 Patients Relieved of Coronavirus Symptoms in 24 Hours After Taking Antibody Cocktail Drug Casirivimab and Imdevimab
Delta Plus: B.1.617.2 Variant Of SARS-CoV-2 Coronavirus First Identified In India, Mutates Further
Monoclonal Antibody Therapy Shows Promising Results For Fast-Progressing Covid-19 Infection Cases
Close to Commit Over $1-BIllion to Moderna for COVID-19 Booster Vaccine; Provide Price Capping Waiver, Indemnity: Cipla to Govt
COVID-19 Antibody Cocktail Is a New Weapon, Casirivimab And Imdevimab Work Against COVID-19 and B.1.617, Says Dr Naresh Trehan
Mohabbat Singh From Haryana Becomes First Person in India To Get COVID-19 Antibody Cocktail of Casirivimab and Imdevimab, Used To Treat Donald Trump
Google Trends